Dysregulated activation of this pathway has been implicated in the pathogenesis of, e.g., RA and SLE, where the survival and differentiation of autoantibody-producing B cells have been shown to rely on non-canonical NF-κB signaling (62). The gene discussed is NFKB1; the disease is systemic lupus erythematosus.